Per-Encounter Medical Market, By Product Type (Consumables, Devices, Software, Services, and Others), By Application (Cardiology, Orthopedics, Obstetrics/Gynecology, Ophthalmology, Gastroenterology, and Others), By Distribution Channel (Direct Tender, Ret

Per-Encounter Medical Market, By Product Type (Consumables, Devices, Software, Services, and Others), By Application (Cardiology, Orthopedics, Obstetrics/Gynecology, Ophthalmology, Gastroenterology, and Others), By Distribution Channel (Direct Tender, Retail Sales, and Online Sales), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Per-encounter medical services refer to medical treatments provided on a per-visit basis, rather than the traditional fee-for-service model. This approach is revolutionizing the healthcare landscape by offering more cost-effective and convenient care options for patients.

Global per-encounter medical market is experiencing considerable growth due to various factors. Patients are increasingly seeking more affordable healthcare options, and per-encounter medical services provide an attractive alternative. Advancements in technology have made it possible to deliver high-quality care remotely, further driving the demand for per-encounter medical services.

Market Dynamics:

Global per-encounter medical market is propelled by several drivers. Firstly, the rising healthcare costs are prompting patients to seek alternative care options that are economically viable. Per-encounter medical services offer transparent pricing and allow patients to pay only for the services they need, thus making healthcare more accessible. Moreover, the increasing prevalence of chronic diseases and the aging population further contribute to the demand for per-encounter medical services. Increasing prevalence of diseases such as cancer and end stage renal disease, which require longer duration therapies (dialysis and chemotherapy) is expected to drive the market growth. For instance, in January 2022according to data published in the Cancer Facts & Figures report by the American Cancer Society, , around 1.9 million new cancer cases was estimated to be diagnosed and 609,360 cancer deaths were reported in the U.S.

However, the market also has restraints. Lack of reimbursement policies and the absence of standardized regulations can hinder the growth of the per-encounter medical market. There may be concerns regarding the quality and continuity of care, as per-encounter medical services focus more on episodic care rather than comprehensive medical management.

Despite these challenges, the per-encounter medical market presents ample opportunities. The growing adoption of telemedicine and remote monitoring technologies provide a potential avenue for expansion. These technologies enable healthcare providers to reach underserved areas and offer healthcare services virtually, thereby fostering the growth of per-encounter medical services. Furthermore, collaborations between healthcare providers and insurance companies can help address reimbursement concerns and drive market growth.

Key features of the study:

• This report provides in-depth analysis of the global per-encounter medical market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global per-encounter medical market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Catalent Inc., Smiths Medical Inc., Cardinal Health, Schott, Nipro Corporation, Terumo Corporation, Gerresheimer AG, Becton, Dickinson and Company, B. Braun Melsungen AG, AngioDynamics Inc., Teleflex Incorporated, Argon Medical Devices, Inc., ICU Medical, Inc., Medical Components, Inc., and Vygon (UK) Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global per-encounter medical market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global per-encounter medical market

Detailed Segmentation:

• Global Per-Encounter Medical Market, By Product Type
• Consumables
• Devices
• Software
• Services
• Others
• Global Per-Encounter Medical Market, By Application
• Cardiology
• Orthopedics
• Obstetrics/Gynecology
• Ophthalmology
• Gastroenterology
• Others
• Global Per-Encounter Medical Market, By Distribution Channel
• Direct Tender
• Retail Sales
• Online Sales
• Global Per-Encounter Medical Market, By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
• Top Companies in Global Per-Encounter Medical Market
• Catalent Inc.
• Smiths Medical Inc.
• Cardinal Health
• Schott
• Nipro Corporation
• Terumo Corporation
• Gerresheimer AG
• Becton, Dickinson and Company
• B.Braun Melsungen AG
• AngioDynamics Inc.
• Teleflex Incorporated
• Argon Medical Devices, Inc.
• ICU Medical, Inc.
• Medical Components, Inc.
• Vygon (UK) Ltd